FDA. Dep. Commissioner; 8/23-1/25. Assoc. Commissioner Leg. Affairs; 2/2022-08/2023. House Com. Energy & Commerce: Chief Health Advisor
2/22-4/19. Sen. Health Policy Advisor, 3/19-3/15. Rep. John D. Dingell - LD, 05/13-07/11. Sen. LA, 7/11-08/09, LA
Covered official positions, as disclosed on federal filings
The past 12 months
Clients
21
past 12 months
Filings
23
past 12 months
Agencies contacted
HOUSE OF REPRESENTATIVESSENATEHealth & Human Services, Dept of (HHS)Centers For Medicare and Medicaid Services (CMS)Food & Drug Administration (FDA)Agriculture, Dept of (USDA)Federal Aviation Administration (FAA)Health Resources & Services Administration (HRSA)Transportation, Dept of (DOT)
Specific issues
Infant Formula Safety, Nutrition, Innovation, and Manufacturing.
Health Issues · 2026 Q1
Regulation of and payment of over-the-counter drugs (OTC), including OTC switches.
Health Issues · 2026 Q1
Issues surrounding improvements to clinical research capabilities and modernization of research methods.
Food Industry (safety, labeling, etc.) · 2026 Q1
Issues surrounding improvements to clinical research capabilities and modernization of research methods. Issues related to preclinical testing safety assessments, including New Approach Methodologies and virtual control groups
Health Issues · 2026 Q1
Community Health Centers Funding, PACE Program
Health Issues · 2026 Q1
Community Health Centers Funding, PACE Program. Issues relating to 340B drug pricing program.